SUMOylation Is Required for Glycine-Induced Increases in AMPA Receptor Surface Expression (ChemLTP) in Hippocampal Neurons by Jaafari, N. et al.
 The University of Bradford Institutional 
Repository 
http://bradscholars.brad.ac.uk 
This work is made available online in accordance with publisher policies. Please refer to the 
repository record for this item and our Policy Document available from the repository home 
page for further information. 
To see the final version of this work please visit the publisher’s website. Available access to 
the published online version may require a subscription. 
Link to publisher’s version: 
http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0052345 
Citation: Jaafari N, Konopacki FA, Owen TF, Kantamneni S, Rubin P, Craig TJ, Wilkinson KA, 
Henley JM (2013) SUMOylation Is Required for Glycine-Induced Increases in AMPA Receptor 
Surface Expression (ChemLTP) in Hippocampal Neurons. PLoS ONE 8(1): e52345. 
Copyright statement: © 2016 The Authors. Published Open Access by PLOS One. Reproduced 
in accordance with the publisher's self-archiving policy, under a Creative Commons attribution 
licence.  
 
SUMOylation Is Required for Glycine-Induced Increases
in AMPA Receptor Surface Expression (ChemLTP) in
Hippocampal Neurons
Nadia Jaafari., Filip A. Konopacki., Thomas F. Owen, Sriharsha Kantamneni, Philip Rubin, Tim J. Craig,
Kevin A. Wilkinson, Jeremy M. Henley*
School of Biochemistry, University of Bristol, Bristol, United Kingdom
Abstract
Multiple pathways participate in the AMPA receptor trafficking that underlies long-term potentiation (LTP) of synaptic
transmission. Here we demonstrate that protein SUMOylation is required for insertion of the GluA1 AMPAR subunit
following transient glycine-evoked increase in AMPA receptor surface expression (ChemLTP) in dispersed neuronal cultures.
ChemLTP increases co-localisation of SUMO-1 and the SUMO conjugating enzyme Ubc9 and with PSD95 consistent with the
recruitment of SUMOylated proteins to dendritic spines. In addition, we show that ChemLTP increases dendritic levels of
SUMO-1 and Ubc9 mRNA. Consistent with activity dependent translocation of these mRNAs to sites near synapses, levels of
the mRNA binding and dendritic transport protein CPEB are also increased by ChemLTP. Importantly, reducing the extent of
substrate protein SUMOylation by overexpressing the deSUMOylating enzyme SENP-1 or inhibiting SUMOylation by
expressing dominant negative Ubc9 prevent the ChemLTP-induced increase in both AMPAR surface expression and
dendritic SUMO-1 mRNA. Taken together these data demonstrate that SUMOylation of synaptic protein(s) involved in AMPA
receptor trafficking is necessary for activity-dependent increases in AMPAR surface expression.
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Introduction
AMPA receptors (AMPARs) mediate most fast excitatory
neurotransmission in the CNS and are key determinants of
neuronal function and dysfunction [1,2]. Increases in the number
and changes in the composition and/or properties of synaptic
AMPARs mediate long-term potentiation (LTP) of synaptic
efficacy whereas their removal leads to long-term depression
(LTD). AMPAR-mediated synaptic plasticity occurs at synapses
throughout the CNS and underlies many neuronal, network and
systems level functions ranging from sensory perception to
intellectual processing [3].
AMPAR trafficking is complex and stringently regulated, and it
is now clear that there are distinct pathways and multiple layers of
control for the delivery, residence time and removal of synaptic
AMPARs. The contribution of each pathway depends on specific
signaling cues and the precise AMPAR subunit composition [1,2].
Although remarkable progress has been achieved towards more
complete understanding of the core mechanisms, fundamental
questions remain about the function and dysfunction of AMPAR
trafficking and synaptic plasticity in health and disease.
Posttranslational modification can direct protein folding,
distribution, stability, activity and function. Consequently, post-
translational modifications are integral to signalling cascades,
especially in the CNS where the processes affecting synaptic
communication between neurons are highly orchestrated. For
example both phosphorylation and ubiquitination have been
extensively studied and play complex roles in postsynaptic protein
regulation [4].
Protein modification by Small Ubiquitin-like MOdifier (SUMO)
has emerged as an important regulator of neuronal function and
dysfunction [5,6]. SUMO is conjugated to lysine residues in target
proteins by a three-enzyme pathway analogous to, but distinct
from, ubiquinitation. A major difference is that unlike for ubiquitin
where there are many E2 conjugating enzymes, Ubc9 is the only
SUMO E2. There are 3 validated SUMO isoforms in mammals,
designated SUMO-1-3. SUMO-2 and -3 differ by only 3 residues,
and are collectively known as SUMO-2/3. SUMOylation is
reversed via the actions of a family of SUMO-specific deconjugat-
ing enzymes, SENPs [7]. In general, SUMO acts by altering the
protein interactions of the substrate protein. We have shown
previously that SUMOylation of the kainate receptor subunit
GluK2a at K886 is required for agonist-induced endocytosis of
GluK2a-containing kainate receptors [8]. More recently, we have
demonstrated that GluK2a SUMOylation is evoked by agonist-
induced PKC phosphorylation of GluK2, and that this phospho-
SUMOylation switch is a crucial determinant of kainate receptor
LTD at mossy fibre synapses [9,10,11]. We, and others have also
identified other synaptic SUMO substrates e.g. [12,13] and
SUMOylation has been implicated in several clinically important
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neurological and neurodegenerative diseases [14]. Interestingly,
although there is currently no evidence to suggest that AMPARs
are direct targets of SUMOylation [8], we have recently
demonstrated that SUMOylation can regulate AMPAR trafficking
during homeostatic synaptic plasticity [13].
We therefore investigated a potential role for SUMOylation in
AMPAR surface expression mediated by more acute forms of
plasticity using a well-characterised glycine stimulation protocol
(ChemLTP) on cultured neurons [15,16]. Our data show that
ChemLTP stimulation recruited SUMO-1 to synapses and
increased co-localisation of SUMO-1 with Ubc9. SUMO-1 and
Ubc9 mRNAs were also increased and trafficked to dendrites
following ChemLTP. Importantly, reducing global levels of
protein SUMOylation by overexpression of a dominant negative
Ubc9 or the catalytic domain of SENP-1 prevented the
ChemLTP-induced increase in GluA1-containing AMPAR sur-
face expression. These data indicate that SUMOylation of
synaptic protein(s) involved in AMPAR trafficking is necessary
for activity-dependent increases in AMPAR surface expression.
Materials and Methods
Primary neuronal culture
All experiments in this study were performed in accordance
with UK Home Office Schedule 1 guidelines. Animals were
sacrificed by cervical dislocation using procedures approved by the
Home Office Licensing Team at the University of Bristol (UIN
UB/12/008).
Rat embryonic hippocampal neuronal cultures were prepared
from E18 Wistar rats using standard procedures. The culture
medium was Neurobasal medium (Gibco) supplemented with B27
(Gibco) and 2 mM glutamine. For some experiments, neurons
were transduced with Sindbis virus at DIV 17–20 and used 18–
24 h later.
Antibodies
The following antibodies are used: N-terminal anti-GluA1
(Millipore), anti PSD95 and anti- b-tubulin (Sigma), SUMO-1 and
SUMO2 (hybridoma bank), UBC9, CPEB, MAP-2 (Sigma).
Chemical LTP (Chem-LTP)
Chem-LTP was induced as described previously [15,17,18].
Briefly, neuronal cultures were transferred from Neurobasal
growth medium to extracellular solution (ECS) containing:
150 mM NaCl, 2 mM CaCl2, 5 mM KCl, 10 mM HEPES
(pH 7.4), 30 mM glucose, 0.5 mM TTX, 1 mM strychnine, 20 mM
bicuculline methiodide. After 5 minutes in ECS, neuronal cultures
were treated with glycine (200 mM) for 3 min in ECS then
incubated in ECS without glycine for different time points (0, 5,
20, 40 min) prior to fixation.
Immunocytochemistry
Following Chem-LTP induction neurons were fixed with 4%
paraformaldehyde (PFA) in PBS for 5 min. Surface GluA1 was
labelled with primary antibody against the N-terminal extracellu-
lar domain (Millipore) and a Cy3-conjugated secondary antibody
(1:500; Jackson Laboratories) under nonpermeant conditions.
Neurons were then fixed for a further 12 min with 4% PFA,
permeabilized using 0.1% Triton X-100 for 10 min and 10%
horse serum and incubated in the same primary antibody and
Cy5-conjugated secondary antibodies to visualise intracellular
receptors. For simple immunolabeling of SUMO and Ubc9 or
SUMO-1, after Chem-LTP induction, neurons were fixed and
permeabilised with either 10 mg/ml digitonin 10 mg/ml or 0.1%
Triton X-100 and 10% horse serum for 10 min. Cells were then
stained with primary and secondary antibodies.
Surface biotinylation
Following ChemLTP induction, neurons were chilled on ice,
washed twice with ice-cold PBS and incubated with 0.15 mg/ml
Sulfo-NHS-SS-Biotin (Pierce) in PBS for 10 min on ice. Cells were
then washed two times with cold PBS, incubated for 5 minutes in
50 mM NH4Cl in PBS, washed three times with PBS and lysed in
lysis buffer (150 mM NaCl, 25 mM HEPES, 1% Triton X-100,
0.1% SDS, 20 mM NEM). After centrifugation, lysate was
incubated with streptavidin–agarose beads for 3 h at 4uC, washed
four times in lysis buffer and bound proteins were detected by
Western blotting.
Fluorescence in situ hybridization
Staining was performed on cultured neurons plated on 13 mm
glass coverslips as described previously using fluorescein-labeled
cRNA probes [19]. Briefly, the following steps were performed: (i)
fixation of tissue in 2% paraformaldehyde/2.5% sucrose for
20 min at room temperature (RT), (ii) permeabilization by
dehydration and rehydration in graded ethanol solutions, (iii)
prehybridization at room temperature, (iv) hybridization with full
length CDS probes of rat SUMO-1, SUMO-2 or UBC9 overnight
at 56uC, (v) posthybridization washes at 56uC with several changes
of SSC buffer with increasing dilution at each rinse, (vi) probe
detection, using peroxidase-conjugated anti-fluorescein antibody
(Roche) followed by red (Cy3) fluorophore-based tyramide signal-
amplification system (NEN, PerkinElmer). Subsequent immuno-
fluorescent co-staining was performed for the dendritic marker
MAP-2 (Sigma). Images were acquired as for immunocytochem-
istry and signal intensity was quantified with ImageJ.
Images analysis and quantification
The images (collapsed stacks of no more than 3 optical sections)
were taken using a Zeiss LSM 510 Meta confocal microscope 636
1.32 NA objective, at 102461024 resolution. Images for all
conditions in a particular experiment were obtained using
identical acquisition parameters and were analyzed using ImageJ
software (NIH). Neurons were selected blind based on EGFP
fluorescence. Quantification of surface AMPARs was carried out
by thresholding the EGFP or fluorescence signal in ImageJ to
define outlines of neurons, and the ratio of surface over total
(surface+internal) fluorescence within this area was calculated.
These values were then normalized to the average surface
fluorescence of untreated control cells. For in situ hybridization
experiments images were analysed by an experimenter blinded to
their identity. Outlines of dendrites and cell bodies were manually
drawn in MAP-2 images and the masks were applied to the in situ
hybridization image and average signal intensity was quantified.
At least 10 cells (up to 5 ROI per cell) for each condition from at
least three independent experiments were analysed.
For presentation, images were processed using Adobe Photo-
shop software (Adobe Systems) by adjusting brightness and
contrast levels to the same degree for all conditions illustrated in
each experiment. Colocalisation of different markers was deter-
mined using the colocalization plug-in in ImageJ. Values were
then normalized to untreated control cells. At least 10 neurons and
3 to 5 ROIs for each condition from three independent
experiments were analysed. Data are expressed as mean 6 s.e.m
and significance was determined using either one way ANOVA
followed by Turkey’s HSD post-hoc test or two-tailed t-tests, as
indicated in the figure legends.
SUMOylation and AMPAR Synaptic Plasticity
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Quantification of SDS–PAGE and immunoblots
Immunoblots from at least three independent experiments were
scanned and analyzed using ImageJ.
Data analysis and statistics
All quantitative data are presented as the means 6 SEM.
Significance values were determined using ANOVA for Figures 1,
2, and 3 (* ,0.015, ** ,0.005, *** ,0.001). For Figure 4 the
significance value is * ,0.01. In Figure 5 only one experimental
condition is compared to its control so significance was determined
by t-test (* ,0.05, ** ,0.01, *** ,0.001).
Results and Discussion
ChemLTP increases AMPAR surface expression
Bath application of 200 mM glycine for 3 min was used to
activate synaptic NMDARs in conjunction with spontaneously
released glutamate in dissociated cortical and hippocampal
neuronal cultures (Figure 1A). The surface expression of AMPARs
was assessed by surface biotinylation and immunostaining of
GluA1. Surface GluA1 in cortical neurons increased to 207616%
after 5 minutes and 195623% after 20 minutes post glycine
stimulation (Figure 1B). Changes in localisation of native AMPAR
subunits in hippocampal neurons were assessed using fixed cell
immunocytochemistry. Surface GluA1 increased to 14168% at
5 min and 13067% 20 minutes after glycine application
(Figure 1C). These findings are consistent with previous reports
for ChemLTP [15,17,18,20] and confirm that the protocol is
effective and robust in our cultures.
ChemLTP increases dendritic SUMO-1 and Ubc9
We next investigated the effects of ChemLTP on proteins
involved in the SUMOylation pathway. We assessed the
immunoreactivities for SUMO-1, SUMO2/3 and Ubc9 in
dendritic regions of fixed, permeabilsed cultured hippocampal
neurons (Figure 2A). ChemLTP caused a rapid increase in
dendritic immunoreactivity of both SUMO-1 and Ubc9. Ubc9
staining was increased to 14867% at 5 min and 13769% at
20 min and SUMO-1 to 16067% at 5 min and 13668% at
20 min. Levels of SUMO-2/3 were unchanged. In addition to
increasing dendritic levels of SUMO-1 and Ubc9, ChemLTP also
increased their colocalisation in dendrites (14066% at 5 min and
13368% at 20 min following ChemLTP; Figure 2B). These data
are consistent with priming of Ubc9 with SUMO-1 for covalent
SUMOylation of target dendritic substrate proteins and/or direct
SUMO-1-ylation of Ubc9 itself [21]. There were no significant
changes in colocalisation between SUMO-2 and Ubc9 following
stimulation.
We also determined if the increase in SUMO-1 occurs at, or
close to postsynaptic sites by colocalisation of SUMO-1 and
PSD95. Colocalisation between SUMO-1 and PSD95 was
increased to 15569% at 5 minutes and 139.668% at 20 minutes
after ChemLTP compared to untreated controls (Figure 2C).
ChemLTP increases SUMO-1 and Ubc9 mRNAs, and levels
of the mRNA binding protein CPEB
We used fluorescence in situ hybridization (FisH) to monitor
levels of SUMO-1, SUMO-2 and Ubc9 mRNAs. Neurons were
stained with anti-MAP-2 antibody to visualize dendrites and
mRNA levels were determined 5, 20 and 40 min after glycine
stimulation. ChemLTP markedly increased SUMO-1 mRNA to
25067% at 5 min; 195615% at 20 min and 165612% at 40 min
compared to control levels. Similarly, mRNA for Ubc9 was
increased to 13869% at 5 min, 22765% at 20 min and 20768%
at 40 min. As with SUMO-2 protein levels, SUMO-2 mRNA
levels were unchanged by ChemLTP (Figure 3A).
Cytoplasmic polyadenylation element binding protein (CPEB) is
an mRNA binding protein involved in translational repression in
the nucleus but that can activate target RNA for translation [22]
and increase dendritic transport of mRNAs, particularly those that
have cytoplasmic polyadenylation element (CPE) [23]. Important-
ly, CPEB is involved in various forms of synaptic plasticity [24]
including the maintenance of LTP [25,26]. The 39 UTR of rat
SUMO-1 has 3 putative CPE sites upstream of two polyadenyl-
ation elements. ChemLTP caused a significant increase in
dendritic CPEB immunoreactivity to 12266% at 20 min and
126610% at 40 min (Figure 3B).
SENP-1 overexpression inhibits ChemLTP-induced
increase in surface AMPARs
SENP-1 plays a role in SUMO maturation and cleaves
covalently bound SUMO-1 and SUMO-2/3 from substrate
proteins. Overexpression of the SENP-1 catalytic domain effec-
tively deSUMOylates neuronal target proteins [27]. Our data
indicate that ChemLTP recruits SUMOylation pathway proteins
to dendrites and spines and increases colocalisation of SUMO-1
and Ubc9. We therefore asked whether protein SUMOylation is
required for ChemLTP. In neurons overexpressing SENP-1
ChemLTP did not increase surface GluA1 (9465% at 20 min
after ChemLTP). As expected, however, ChemLTP effectively
increased GluA1 surface expression in cells overexpressing the
inactive point mutant SENP-1(C603S) (127611% at 20 min;
Figure 4A).
To further confirm the involvement of SUMOylation in
ChemLTP we overexpressed a dominant-negative Ubc9 (DN-
Ubc9; [28]). Neurons expressing GFP showed a robust increase in
surface GluA1 in response to ChemLTP (182622% at 20 min
after ChemLTP), however this was blocked in neurons expressing
GFP-DN-Ubc9 (Figure 4B). Indeed, unexpectedly, in cells
expressing GFP-DN-Ubc9 we observed a significant decrease in
surface GluA1 after ChemLTP (6766% at 20 min after
ChemLTP). While the reason for this decrease in GluA1 surface
expression is unclear, taken together these data indicate that
protein SUMOylation is required for the increase in GluA1
surface expression following ChemLTP.
SENP-1 reduces the ChemLTP increased transcription of
SUMO-1 mRNA
Our findings indicate that SUMO-1 is recruited to dendrites in
response to ChemLTP. The mRNAs encoding many proteins
involved in plasticity are translocated along dendrites and undergo
local translation close to synapses. Having shown that protein
deSUMOylation inhibits ChemLTP we next asked if deSUMOy-
lation affected levels and dendritic delivery of SUMO-1 mRNA.
We therefore tested the effects of SENP-1 overexpression on
SUMO-1 mRNA expression and dendritic translocation. In
control neurons expressing inactive SENP-1(C603S) there was a
significant increase in the amount of SUMO-1 mRNA in the cell
body (146611%) at 20 minutes post ChemLTP. In neurons
expressing active SENP-1, however, there was no significant
change in SUMO-1 mRNA (Figure 5A). Similarly, in SENP-
1(C603S) expressing neurons dendritic SUMO-1 mRNA signifi-
cantly increased at 20 minutes after ChemLTP (168610%),
whereas there was no significant change in neurons expressing
SENP-1 WT (Figure 5B). The specificity of the in situ hybridization
procedure was validated using a sense probe, which yielded almost
SUMOylation and AMPAR Synaptic Plasticity
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Figure 1. ChemLTP increases GluA1 surface expression. A) Schematic of the ChemLTP protocol. Dissociated hippocampal neuronal cultures
(DIV 17–20) were treated with glycine (200 mM) for 3 min, then incubated in media without glycine for 5, 20 or 40 min. B) ChemLTP increases surface
GluA1. Graph shows quantification of the ratio of surface to total GluA1. Statistical significance was determined using ANOVA. n= 5 ***p,0.005,
***p,0.001. C) ChemLTP Increases surface expression of endogenous GluA1-containing AMPARs in dissociated hippocampal neurons expressing
EGFP. Surface and internal GluA1 were sequentially labeled under non-permeabilised and permeabilised conditions, respectively, with different
coloured secondary antibodies. Representative images are shown. Graph shows surface:internal ratio relative to unstimulated control. n = 12–15 cells
per condition in 3 independent experiments. ANOVA **p,0.005 and ***p,0.001. Scale bars – 20 mm.
doi:10.1371/journal.pone.0052345.g001
SUMOylation and AMPAR Synaptic Plasticity
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Figure 2. ChemLTP upregulates of SUMO-1 and Ubc9 protein levels. A) ChemLTP increases in SUMO-1 and Ubc9 immunoreactivity with no
change in the intensity of SUMO-2 staining. Mean fluorescence intensity was analysed using ImageJ. Graphs show quantification of 3 independent
experiments, 10 neurons per condition (ANOVA. *p,0.02; **p,0.005). Scale bars – 20 mm. B) ChemLTP enhances colocalization between SUMO-1
and Ubc9, and SUMO-2/3 and Ubc9 in cultured hippocampal neurons. Example of dendritic segments stained for SUMO-1 (upper panel) or SUMO-2
(lower panel) protein (blue) and Ubc9 (red). Colocalized puncta were quantified using JACoP plugin in ImageJ. Analysis was made in at least 3
different ROIs for each neuron (n = 10), for each condition in 3 independent experiments. (ANOVA. *p,0.02; **p,0.005). C) ChemLTP increases
SUMO-1 clusters at synapses. Examples of fluorescence images of dendrites stained for SUMO-1 and PSD95. The colocalized clusters are indicated as
yellow puncta. Graph shows quantification of SUMO-1/PSD95 colocalizing pixels. Analysis was performed in at least 3 independent experiments with
10 neurons per condition and 3 ROIs per neuron, using JACoP plugin in ImageJ. Statistical significance was determined using ANOVA. *p,0.02;
**p,0.005.
doi:10.1371/journal.pone.0052345.g002
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Figure 3. ChemLTP increases SUMO-1 and Ubc9 mRNA. A) Fluorescent in situ hybridization using cRNA probes for SUMO-1, SUMO-2 and Ubc9
(red) in hippocampal neurons co-stained with the dendritic marker MAP-2 (green). ChemLTP increased levels of SUMO-1 and Ubc9 but not SUMO-2
mRNA in soma and dendrites. Mean fluoresence intensity was quantified in at least 3 independent experiments with 10 neurons per condition and 3
ROIs per neuron using ImageJ. B) ChemLTP increases levels of the mRNA binding protein CPEB1 (red) in hippocampal cultured neurons co-
immunostained with MAP2 (green). Three independent experiments with 8 neurons per condition and 4 ROIs per neuron were quantified using
JACoP plugin in ImageJ. Statistical significance was determined using ANOVA *p,0.02; **p,0.005. Scale bars – 20 mm.
doi:10.1371/journal.pone.0052345.g003
SUMOylation and AMPAR Synaptic Plasticity
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no signal compared to the anti-sense (experimental) probe
(Figure 5C). These results suggest that the ChemLTP-induced
increase SUMO-1 mRNA is mediated via a pathway that requires
protein SUMOylation. Also, the rise in dendritic levels are
consistent with local translation of SUMO-1 mRNA playing a role
in glycine-induced long-term increase of surface AMPARs.
We show that SUMOylation is necessary for ChemLTP-
induced increase of surface AMPARs. Blocking protein SUMOy-
lation either through overexpression of the catalytic domain of
SENP-1, which removes both SUMO-1 and SUMO-2/3 from
substrates, or overexpresssion of a dominant negative form of
Ubc9, the sole SUMO-specific conjugating enzyme, prevents the
increase in surface AMPARs in response to glycine stimulation.
These data strongly suggest that SUMOylation is required for the
activity-dependent trafficking of AMPARs that underlies LTP.
We have previously demonstrated that protein SUMOylation
regulates kainate receptor trafficking and plasticity [8,9,10].How-
ever, while the effect of protein SUMOylation on kainate receptor
plasticity is mediated through direct modification of the KAR
subunit GluK2 [10], we have been unable to detect direct
SUMOylation of AMPAR subunits. Thus, SUMOylation of
protein(s) involved in activity-dependent AMPAR trafficking is
necessary for the ChemLTP-mediated increase in AMPAR surface
expression. The identity of these proteins is currently unclear but
there are multiple potential candidate SUMO substrate proteins
that might directly or indirectly influence AMPAR trafficking
[13,29].
ChemLTP increases SUMO-1 and Ubc9 proteins in dendrites
and an accumulation of SUMO-1 at synapses, visible as early as
5 minutes after glycine stimulation. In addition, ChemLTP leads
to an increase in the colocalisation of SUMO-1 with Ubc9. This
can represent either non-covalent SUMO loading of Ubc9 for
subsequent conjugation to target proteins and/or direct SUMOy-
lation of Ubc9 to regulate substrate discrimination [21]. Indeed,
the latter possibility may provide a mechanism for targeting
specific proteins for SUMOylation during LTP.
In addition to the recruitment and colocalisation of SUMO-1
and Ubc9, our fluorescence in situ hybridization data demonstrate
Figure 4. Overexpression of SENP-1 or dominant-negative Ubc9 inhibits the ChemLTP-mediated increase in surface GluA1. A, B)
Overexpression of active SENP-1 (A) catalytic domain, but not inactive SENP-1(C603S) (B), abolishes the ChemLTP-mediated increase in surface
expression of GluA1 as determined by surface biotinylation and immunoblotting. The corresponding bar graphs show quantification of surface/total
GluA1 ratio. Statistical significance was determined using Student’s t-test. C, D) Dominant-negative Ubc9 blocks the ChemLTP-mediated increase in
surface GluA1. Neurons were infected with virus expressing dominant-negative Ubc9 (DN-Ubc9) (C) or control GFP (D) and subjected to ChemLTP.
Surface biotinylation and western blotting were used to monitor changes in surface expression. Corresponding graphs show quantification of
surface/total GluA1 ratio. Statistical significance was determined using Student’s t-test. n = 4 (A and B) or n = 3 (C and D) *p,0.02.
doi:10.1371/journal.pone.0052345.g004
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that ChemLTP increases SUMO-1 and Ubc9 mRNA. Thus,
ChemLTP stimulates both the transcription of SUMO-1 and
Ubc9 mRNA and synaptic targeting of pre-existing SUMO-1 and
Ubc9 proteins. Furthermore, our results suggest that SUMOyla-
tion of yet unknown target proteins regulates SUMO-1 mRNA
transcription and possibly dendritic transport.
It is a well-established concept that translocation of mRNA to
dendrites followed by local translation is an important mechanism
contributing to LTP [30,31]. ChemLTP increases SUMO-1
mRNA in the soma and dendrites suggesting ChemLTP-induced
active transport of SUMO-1 mRNA to dendrites, further
indicating that SUMO-1 is as a plasticity-related gene. Thus, the
observed increase in SUMO-1 protein in dendrites at 5 minutes
after stimulation may be due in part to local translation of pre-
existing dendritic mRNA, which is subsequently replenished at
later stages of LTP. Such mode of action has been observed in
other plasticity-related mRNA species [19]. Consistent with this,
ChemLTP increases the dendritic localization of the RNA binding
Figure 5. Overexpression of SENP-1 diminishes the ChemLTP-mediated increase in SUMO-1 mRNA. A) Representative images showing
effects of ChemLTP in the soma and processes of hippocampal neurons overexpressing SENP-1 C603S (inactive control) or SENP-1 WT (green).
Fluorescence in situ hybridization was performed using cRNA probes for SUMO-1 (red). Neurons were then co-stained with MAP-2 (blue). Graph
shows quantification of mean fluorescence intensity (arbitrary units) in soma quantified from 4 independent experiments with 8–12 neurons per
condition using ImageJ. B) Representative examples of dendritic regions of neurons overexpressing SENP-1 C603S (inactive control) or WT. Graph
shows quantification of mean fluorescence intensity (arbitrary units) in dendrites. Quantification from 4 independent experiments; each experiment:
8–12 neurons per condition and 4 dendrites per neuron, done using ImageJ Scale bars – 5 mm. C) In situ hybridization with SUMO-1 negative control
(sense probe) yielded virtually no signal compared to the anti-sense (experimental) probe. Scale bars – 20 mm. In all cases statistical significance was
determined using ANOVA followed by Bonferroni post-hoc test (*p,0.01).
doi:10.1371/journal.pone.0052345.g005
SUMOylation and AMPAR Synaptic Plasticity
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protein CPEB-1. CPEB-1 mediates cytoplasmic activity-depen-
dent mRNA polyadenylation and translation through binding to
cytoplasmic polyadenylation elements (CPEs) with the consensus
59-UUUUAU-39 present in the 39UTR of target mRNAs [24].
CPEB has also been shown to be important for the dendritic
transport of mRNAs containing CPEs [23] but it has not yet been
determined whether it interacts directly with SUMO-1 mRNA in
neurons. However, taken together, these results support the
concept that SUMO-1 is as a plasticity-related gene.
In summary, we show that SUMOylation is required for the
initial insertion of AMPA receptors during the induction of
ChemLTP. Additionally our data indicate that ChemLTP
induction in turn upregulates the SUMOylation machinery at
both the mRNA and protein levels, as well as increasing the
association of SUMO-1 with the sole SUMO conjugating enzyme
Ubc9.
Thus, we hypothesize that the initial AMPAR insertion
observed upon the induction of LTP is mediated by either pre-
existing SUMO-1 and Ubc9 proteins, or proteins newly translated
from pre-existing dendritic mRNAs. Potentially, this initial
increase is stabilized through the LTP-induced transcription of
SUMO-1 and Ubc9 mRNAs and their further local translation in
dendrites. While we do not yet know the identity of the SUMO
substrate proteins that regulate these pathways there are many
interacting and signaling proteins involved in AMPAR trafficking
that either contain consensus SUMOylation motifs or have
already been demonstrated to be SUMO targets [6]. Importantly,
the function and dysfunction of neuronal SUMOylation has been
strongly implicated multiple neurological and neurodegenerative
diseases [14]. Thus, our findings highlight protein SUMOylation
as a crucial mediator of AMPAR insertion during LTP and reveal
a potential role for SUMOylation in the pathogenesis of disorders
of the nervous system that are characterized by defective AMPAR
trafficking and plasticity.
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